Hao Guo

3.5k total citations · 1 hit paper
62 papers, 1.5k citations indexed

About

Hao Guo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Hao Guo has authored 62 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Oncology, 22 papers in Pulmonary and Respiratory Medicine and 17 papers in Cancer Research. Recurrent topics in Hao Guo's work include HER2/EGFR in Cancer Research (17 papers), Cancer Treatment and Pharmacology (16 papers) and Advanced Breast Cancer Therapies (14 papers). Hao Guo is often cited by papers focused on HER2/EGFR in Cancer Research (17 papers), Cancer Treatment and Pharmacology (16 papers) and Advanced Breast Cancer Therapies (14 papers). Hao Guo collaborates with scholars based in United States, China and India. Hao Guo's co-authors include Eric P. Winer, Zhan Xu, Sara M. Tolaney, Beth Overmoyer, William T. Barry, Ian E. Krop, Antonio C. Wolff, Beverly Moy, Harold J. Burstein and Matthew J. Ellis and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Hao Guo

59 papers receiving 1.4k citations

Hit Papers

Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HE... 2015 2026 2018 2022 2015 100 200 300 400

Peers

Hao Guo
Ji‐Yeon Kim South Korea
Musa Mayer United States
Richat Abbas United States
Payal D. Shah United States
Jane Yanagawa United States
Leonard Reyno United States
Hao Guo
Citations per year, relative to Hao Guo Hao Guo (= 1×) peers Elisa Agostinetto

Countries citing papers authored by Hao Guo

Since Specialization
Citations

This map shows the geographic impact of Hao Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Guo more than expected).

Fields of papers citing papers by Hao Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hao Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Guo. The network helps show where Hao Guo may publish in the future.

Co-authorship network of co-authors of Hao Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Hao Guo. A scholar is included among the top collaborators of Hao Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hao Guo. Hao Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Hao, et al.. (2024). S-ketamine Infusion on Chronic Postoperative Pain Following Breast Cancer Surgery: A Randomized Double-Blind Placebo-Controlled Trial. Clinical Breast Cancer. 24(7). e605–e612. 2 indexed citations
2.
Yang, Rong, Hao Guo, Zhuoxi Wu, et al.. (2024). Molecular Basis of VCPIP1 and P97/VCP Interaction Reveals Its Functions in Post‐Mitotic Golgi Reassembly. Advanced Science. 11(41). e2403417–e2403417. 4 indexed citations
3.
Xu, Qi, Zhuoxi Wu, Jialu Li, et al.. (2024). The structural basis of the activation and inhibition of DSR2 NADase by phage proteins. Nature Communications. 15(1). 6185–6185. 2 indexed citations
4.
Tang, Liang, Hao Guo, Keyi Wang, et al.. (2023). Low-intensity pulsed ultrasound enhances the positive effects of high-intensity treadmill exercise on bone in rats. Journal of Bone and Mineral Metabolism. 41(5). 592–605. 5 indexed citations
5.
Parsons, Heather A., Erin Macrae, Hao Guo, et al.. (2021). Phase II Single-Arm Study to Assess Trastuzumab and Vinorelbine in Advanced Breast Cancer Patients With HER2-Negative Tumors and HER2-Positive Circulating Tumor Cells. JCO Precision Oncology. 5(5). 896–903. 13 indexed citations
6.
Goel, Shom, Jia Liu, Hao Guo, et al.. (2019). Decline in Left Ventricular Ejection Fraction Following Anthracyclines Predicts Trastuzumab Cardiotoxicity. JACC Heart Failure. 7(9). 795–804. 30 indexed citations
7.
Barroso‐Sousa, Romualdo, William T. Barry, Hao Guo, et al.. (2019). The immune profile of small HER2-positive breast cancers: a secondary analysis from the APT trial. Annals of Oncology. 30(4). 575–581. 21 indexed citations
8.
Li, Zhen, Shuan Li, Yu Liu, et al.. (2017). TNF-α -308 A allele is associated with an increased risk of distant metastasis in rectal cancer patients from Southwestern China. PLoS ONE. 12(6). e0178218–e0178218. 6 indexed citations
9.
Shinagare, Atul B., Bhanusupriya Somarouthu, Hao Guo, Sara M. Tolaney, & Nikhil H. Ramaiya. (2017). Occurrence and significance of morphologic changes in patients with metastatic triple negative breast cancer treated with Cabozantinib. Clinical Imaging. 48. 44–47. 2 indexed citations
10.
Zhang, Zhixiang, et al.. (2016). Effects of Platelet-Derived Endothelial Cell Growth Factor and Doppler Perfusion Index in Patients with Colorectal Hepatic Metastases. Visceral Medicine. 32(3). 206–210. 2 indexed citations
11.
Warren, Laura, Hao Guo, Meredith M. Regan, et al.. (2015). Inflammatory Breast Cancer: Patterns of Failure and the Case for Aggressive Locoregional Management. Annals of Surgical Oncology. 22(8). 2483–2491. 26 indexed citations
12.
Tolaney, Sara M., Sally Tan, Hao Guo, et al.. (2015). Phase II study of tivantinib (ARQ 197) in patients with metastatic triple-negative breast cancer. Investigational New Drugs. 33(5). 1108–1114. 47 indexed citations
13.
Ruddy, Kathryn J., Hao Guo, William T. Barry, et al.. (2015). Chemotherapy-related amenorrhea after adjuvant paclitaxel–trastuzumab (APT trial). Breast Cancer Research and Treatment. 151(3). 589–596. 49 indexed citations
14.
Tolaney, Sara M., William T. Barry, Chau T. Dang, et al.. (2015). Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer. New England Journal of Medicine. 372(2). 134–141. 458 indexed citations breakdown →
16.
Warren, Laura, Hao Guo, Meredith M. Regan, et al.. (2015). Inflammatory breast cancer and development of brain metastases: risk factors and outcomes. Breast Cancer Research and Treatment. 151(1). 225–232. 21 indexed citations
17.
Ruddy, Kathryn J., Stephen DeSantis, William T. Barry, et al.. (2014). Extended Therapy With Letrozole and Ovarian Suppression in Premenopausal Patients With Breast Cancer After Tamoxifen. Clinical Breast Cancer. 14(6). 413–416. 12 indexed citations
18.
Mayer, Erica L., Lyndsay N. Harris, Julie Gold, et al.. (2014). Long-Term Follow-Up After Preoperative Trastuzumab and Chemotherapy for HER2-Overexpressing Breast Cancer. Clinical Breast Cancer. 15(1). 24–30. 11 indexed citations
19.
Gao, Chunyan, Yue-hong Lu, Tian Cheng-rui, et al.. (2011). Main nutrients, phenolics, antioxidant activity, DNA damage protective effect and microstructure of Sphallerocarpus gracilis root at different harvest time. Food Chemistry. 127(2). 615–622. 35 indexed citations
20.
Espinoza, Sara, Hao Guo, Neal S. Fedarko, et al.. (2008). Glutathione Peroxidase Enzyme Activity in Aging. The Journals of Gerontology Series A. 63(5). 505–509. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026